To Compare The Therapeutic Efficacy And Safety Of Fexofenadine With Chlorpheniramine Maleate In The Treatment Of Allergic Rhinitis And Bethmethasone, Short Course Therapy Given Orally In Allergic Rhinitis | 4726
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Google scholar citation report
Citations : 1514

Journal of Biotechnology & Biomaterials received 1514 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

To compare the therapeutic efficacy and safety of fexofenadine with chlorpheniramine maleate in the treatment of allergic rhinitis and bethmethasone, short course therapy given orally in allergic rhinitis

3rd World Congress on Biotechnology

G. Arun Jyothi

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

INTRODUCTION:Allergies are among the most common diseases affecting millions of people throughout the world. A significant percentage of Indian population affects from one or the other allergic disorders. Allergic rhinitis is one of the commonest allergic disorders. It is sensitization of the nasal mucosa by the allergens leads to the allergic response in the nasal cavity resulting in the typical symptoms of sneezing, watery nasal discharge, itching and blocking of nose. These symptoms cause considerable disturbance to the normal daily activities and even be a forerunner for more severe forms of allergy like Bronchial Asthma. The present treatment options for Allergic Rhinitis include: Oral Antihistamines, Topical Corticosteroids, Oral Corticosteroids (Short Course), Topical Anticholinergics and Immunotherapy (Desensitization) of all these Anti Histamines are the most commonly used. OBJECTIVE: 1] Comparing the therapeutic efficacy and safety of second generation anti histamine eg:fexofenadine with first generation eg:chlorpheniramine maleate. 2] Comparing the therapeutic efficacy and safety of Anti histamines with other group of drug used in allergic rhinitis ( i.e)Bethamethasone orally short course. INCLUSION CRITERIA: patients between age 15-45. Number of cases 75. METHODS: ENT examination.complete Blood Picture,Absolute eosinophil count, X Ray of paranasal sinuses,skin test for Allergy, IgE levels in the serum. CONCLUSION: The three drugs fexofenadine, chlorpheniramine maleate and Bethamethasone were and found to have similar levels of efficacy in controlling the symptoms of allergic rhinitis. The physical signs improved better with chlorpheniramine than other two drugs. Fexofenadine was found to be most effective in suppression of the skin reaction to the allergens. It was closely followed by Betamethasone and then chlorpheniramine. The anti-histamines Fexofenadine and Chlorpheniramine had no significant effect on the absolute eosinophil count and serum ?IgE levels. Whereas Betamethasone had significant effects. Adverse effects were reported more by patients on chlorpheniramine maleate than with Fexofenadine or Bethamethasone.